Pharma channel feed – Endpoints News

Pharma channel feed

China corruption crackdown hits Merck’s Gardasil sales, spooking investors

10 months ago

Behind Boehringer’s up to $1.3B Nerio deal is a budding cancer pipeline and aim to ‘leapfrog AbbVie’

10 months ago

Incyte drops four early-stage programs from its pipeline as part of strategic review

10 months ago

Pfizer ups 2024 guidance by $1B after multiple rounds of cost cuts

10 months ago

Keytruda tops $7B quarterly sales for the first time

10 months ago

AstraZeneca and Daiichi Sankyo fail to win NICE recommendation for Enhertu, call for change to review process

10 months ago

FDA's ad enforcer critiques Brittany Mahomes' paid Instagram post for Kaléo

10 months ago

Boehringer Ingelheim buys oncology biotech for up to $1.3B

10 months ago

NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

10 months ago

Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology

10 months ago

Compounded weight loss drugs have resulted in misdosing, hospitalizations, FDA warns

10 months ago

Among pharma CEOs, the IRA now and the IRA later get very different reactions

10 months ago

Pfizer and BioNTech say GSK's Covid patent suit is 'groundless'

10 months ago

Updated: Bristol Myers restarts radiopharmaceutical Phase 3 trial

10 months ago

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

10 months ago

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

10 months ago

FDA approves Sun Pharma's JAK inhibitor Leqselvi for hair loss in adults

10 months ago

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

10 months ago

FDA advisors call for better studies of immunotherapy around lung cancer surgery, but give AstraZeneca a pass

10 months ago

EU panel follows FDA’s lead on Wegovy, recommending use to prevent cardiac events

10 months ago

Ipsen loses legal appeal over whether blockbuster cancer treatment is a drug or biologic

10 months ago

Taking advantage of recent successes, Roche will push obesity drugs faster, flirts with M&A

10 months ago

AbbVie beats expectations with smaller Humira slide — and big gains for next autoimmune blockbusters

10 months ago

AstraZeneca details ‘very ambitious’ strategy for early-stage obesity programs

10 months ago

First page Previous page 44 45 464748 49 50 Next page Last page